RCP Multi-morbidity conference - Monday 1st July 2019

Event Date: 
Monday, 1 July, 2019

Cardiovascular, metabolic and kidney disease: crosscutting science and best practice Are you involved with patients who have multimorbidity? This 1-day conference, held on 1 July 2019, will look at updates in multimorbidity and the clustering of common diseases in patients.

Evoking discussion and dialogue on ways to improve the health of these patients, the conference offers a packed programme full of interactive sessions and take-home messages for direct use on the ward.

Topics covered will look at: the latest insights from industry regarding the treatment of inflammation and fibrosis; how digital health and AI are driving research on delivering personalised medicine to patients; the epidemiology of multimorbidity in vascular disease.

Hurry! Book by 20 May to receive your early-bird discount.http://www.rcplondon.ac.uk/Cardiometabolic2019

This unique conference to be held at the RCP aims to stimulate discussion and ideas in addressing multi-morbidity and clustering of diseases which are a major problem for health service providers. It straddles all 5 related specialties in Division 2 of the NIHR CRN portfolio, namely cardiovascular disease, stroke, diabetes, metabolic disease and nephrology. There is a need for greater integration of clinical and basic science research and pathogenetic understanding between these disease clusters, with shared treatments developed to address common pathways. The conference will be of value to clinicians, scientists and other members of the multi-professional team, as well as Pharma representatives. Please consider attending.

 

Cardiovascular, metabolic and kidney disease: crosscutting science and best practice in multi-morbidity

Monday 1 July 2019

Royal College of Physicians, 11 St Andrews Place, Regent’s Park, London NW1 4LE

Programme organiser: Professor Philip Kalra, Renal Association

 

09.00

Registration and coffee

09.25 

Welcome and opening remarks
Professor Philip Kalra, Renal Association

 

Session 1: The challenges from a point of care perspective
Chair: Professor Philip Kalra, Renal Association

09.30

Multi-morbidity at the coal face

Professor Jackie Taylor, Royal College of Physicians and Surgeons of Glasgow

 

Session 2: Epidemiology and health inequalities in the multi-morbid population

Chair: Professor John Wilding, University of Liverpool

10.00

Epidemiology of multi-morbidity in the UK

Dr Dorothea Nitsch, Royal Free London NHS Foundation Trust

10.20         

The healthcare providers’ perspective: current and future policy

Professor Stephen Powis, NHS England

10.40

The funder’s perspective: multi-morbidity and translating basic science into the best clinical trials

Professor Paul Elliott, Imperial College London

11.00

 

        11.10

Q&A

 

Coffee

 

Session 3: Accelerating research using current data and sample resources

Chair: Professor Tom Robinson, University of Leicester

11.30

Data sets: NHS digital, UK Renal Registry, NICOR, Stroke Registry and Diabetes National Audit CPRD

Dr Fergus Caskey, University of Bristol

11.50         

Research networks and existing cohorts

Professor David Wheeler, University College London

        12.10

Biomarkers

Professor Maarten Taal, University of Nottingham

12.30

Lunch

 

 

Session 4: Underpinning scientific development and methodological issues

Chair: Professor Paul Cockwell, University Hospitals Birmingham

13.30

Omics potential

Professor Desmond Johnston, Imperial College Healthcare

13.50

Imaging potential

Professor Sue Francis, University of Nottingham

        14.10

Devices and telemonitoring

Professor Martin Cowie, Imperial College London

 

Session 5: Current and future industry plans for multi-morbidity research

Chair: Dr Claire Sharpe, King’s College London

14.30

Improving multi-morbidity with newer anti-diabetic therapies

Professor John McMurray, University of Glasgow

14.50         

Medicine development

Tim Johnson, UCB and Professor Robert Unwin, AstraZeneca

        15.20

Tea

 

Session 6: UK clinical platform for multi-morbidity research

Chair: Professor John Feehally, University of Leicester and Professor Simon Heller, University of

Sheffield

15.50

Panel session

TBC

16.40         

Proposed way forward

Professor Philip Kalra, Renal Association

        16.55

 

      

        17.00

Closing remarks

Professor Philip Kalra, Renal Association and Sandra Currie, Kidney Research UK

 

Close of conference

Event taxonomy: 
Other charity /not-for-profit
Discipline: 
Diabetes
Clinical taxonomy: 
Cardiovascular, Co-morbidities, Diabetic nephropathy, Type 1 diabetes mellitus, Type 2 diabetes mellitus